Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis

Background Cystic fibrosis is an inherited condition resulting in thickened, sticky respiratory secretions. Respiratory failure, due to recurrent pulmonary infection and inflammation, is the most common cause of mortality. Muco‐active therapies (e.g. dornase alfa and nebulized hypertonic saline) may...

Ausführliche Beschreibung